Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

VR (VR-Control)

PreclinicalSmall molecule

PProf. Dominique de Quervain, MD

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

BreathingRecruiting

BreathingPreclinical

Recruiting

Timeline

Expected Milestones

Q4 2026

PreclinicalRecruiting

Breathing

NCT07191288

Clinical

Trials by Indication[1]

Breathing1 trial

Assessing the Acute Effects of Virtual Reality Interventions on Stress: A Four-Arm RCT

Recruiting·PProf. Dominique de Quervain, MD·Preclinical·NCT07191288·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for VR (VR-Control). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — VR (VR-Control) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for VR (VR-Control). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Prof. Dominique de Quervain, MD company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: PProf. Dominique de Quervain, MD

Related News